The Predictive Role of Hematological Parameters in Hypertension

Xiangzhu Meng1, Hong Sun2, Xiaowen Tu1

  • 1Department of Cardiology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, Jiangxi, China.

Angiology
|July 17, 2023
PubMed

Insights

New hematological parameters can help predict hypertension (HT) and its complications. These inexpensive markers, including neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII), offer valuable insights for early screening and patient management.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Inflammation Research

Background:

  • Hypertension (HT) is a major global health issue, linked to target-organ damage and cardiovascular mortality.
  • Inflammation is increasingly recognized as a key factor in HT development and progression.
  • Conventional inflammatory markers for HT are often costly and less accessible than routine blood tests.

Purpose of the Study:

  • To review the diagnostic and prognostic value of novel hematological parameters in hypertension.
  • To assess the utility of parameters like NLR, MHR, RDW, PLR, MPV, PDW, and SII as biomarkers for HT.

Main Methods:

  • Comprehensive literature search of PubMed and Embase databases up to September 18, 2022.
  • Analysis of studies investigating the association between hematological parameters and hypertension.
  • Focus on parameters reflecting inflammation and platelet activation.

Main Results:

  • Several hematological parameters, including neutrophil-to-lymphocyte ratio (NLR), monocyte to HDL cholesterol ratio (MHR), red cell distribution width (RDW), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), platelet distribution width (PDW), and systemic immune-inflammation index (SII), show potential as HT biomarkers.
  • These parameters are easily obtainable from routine blood tests and are cost-effective.
  • Evidence suggests their utility in predicting HT diagnosis and prognosis.

Conclusions:

  • Hematological parameters offer a promising, accessible approach for early hypertension screening and risk stratification.
  • These biomarkers can aid in optimizing the management strategies for patients with hypertension.
  • Further research into these parameters can enhance cardiovascular disease prevention and treatment.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
1.3K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.3K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
27
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.4K